anticancer/headache

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 482 rezilta yo

[Antineoplastic drug and headache].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Patients with cancer often take multiple medications. These medications may be directed at underlying neoplasms or at secondary symptoms. These chemotherapeutic agents may have other actions on the central nervous system. Accordingly the various mechanisms inducing neurotoxicity, especially headache

[Headache as "sentinel" symptom in personnel involved in the preparation and administration of antineoplastic drugs].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The increased prevalence of neoplastic diseases observed over the last years has resulted for in more frequent operations of preparation and administration of antiblastic drugs performed by the medical personnel. In this study, we examined a group of subjects involved in the preparation of ACNU,

Hydrophobic constituents and their potential anticancer activities from Devil's Club (Oplopanax horridus Miq.).

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Devil's Club (Oplopanax horridus) is one of the most important spiritual and medicinal plants to many indigenous peoples of Alaska and the Pacific Northwest. It is widely used for external and internal infections as well as arthritis, respiratory ailments, digestive tract ailments, broken

Evaluation of anticancer activity of ethanol extract of Sesbania grandiflora (Agati Sesban) against Ehrlich ascites carcinoma in Swiss albino mice.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND The plant Sesbania grandiflora (Fabaceae) is commonly known as "Sesbania" and "agathi" in ayurvedic system of medicine and reputed in the indigenous medicine in India. It is also known as "Agati Sesban" or "humming bird tree" in English. All parts of this unique plant are useful and have

Unique aspects of supportive care using monoclonal antibodies in cancer treatment.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The "magic bullet" era of targeted cancer therapy began with the United States Food and Drug Administration approval of rituximab for the treatment of B-cell lymphoma in the late fall of 1997. Since then, several additional anticancer antibody products have received regulatory approval, including

Migraine-type headaches in children receiving chemotherapy and ondansetron.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Six children developed severe daily migraine-type headaches during cancer treatment. In addition to chemotherapy drugs, all received daily doses of ondansetron, a 5-hydroxytryptamine type 3 receptor antagonist. 5-Hydroxytryptamine is considered to play a central role in migraine pathogenesis, and

Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE A randomized trial was performed to investigate the ability of the nucleoside transport inhibitor dipyridamole (DP) to enhance the antitumor activity of fluorouracil (5-FU)/leucovorin (folinic acid [FA]). METHODS One hundred eighty-one untreated patients with advanced colorectal cancer

Fatal cesium chloride toxicity after alternative cancer treatment.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Cesium chloride (CsCl) is sold as a treatment for several types of cancers. The purported mechanism of action is alkalinization of relatively acidic neoplastic cells. The efficacy of CsCl has not been demonstrated in controlled experiments. Oral and intravenous CsCl use has been

In vitro antioxidant and anticancer effects of solvent fractions from Prunella vulgaris var. lilacina.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Recently, considerable attention has been focused on exploring the potential antioxidant properties of plant extracts or isolated products of plant origin. Prunella vulgaris var. lilacina is widely distributed in Korea, Japan, China, and Europe, and it continues to be used to treat

Antimutagenic Effect of Medicinal Plants Achillea millefolium and Bauhinia forficata In Vivo.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The investigation of traditionally used medicinal plants is valuable both as a source of potential chemotherapeutic drugs and as a measure of safety for the continued use of these medicinal plants. Achillea millefolium L. (AM) is an ancient remedial herb native to Europe that is used to treat

Isolation of an oleanane-type saponin active from Bellis perennis through antitumor bioassay-guided procedures.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Bellis perennis L. (Asteraceae) (common daisy) is a herbaceous perennial plant known as a traditional wound herb; it has been used for the treatment of bruises, broken bones, and wounds. Bellis perennis has also been used in the treatment of headache, common cold, stomachache, eye

Ethnomedicinal, Phytochemical and Pharmacological Profile of Anthriscus sylvestris as an Alternative Source for Anticancer Lignans.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Anthriscus sylvestris (L.) Hoffm. is a wild herbaceous plant common in most temperate regions. It has been used traditionally to treat headaches, as a tonic, as antitussive, antipyretic, analgesic and diuretic. The plant contains deoxypodophyllotoxin, which is proven to have antitumor and

[Clinical phase II study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drugs].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A comparative clinical trial of tropisetron capsule was conducted in three dose groups to investigate its optimal dose on nausea and vomiting induced by anti-cancer drugs, including cisplatin. The doses were randomized by the central registration office. In the assessment of clinical efficacy, cases

Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Tropisetron (ICS 205-930) antagonizes the serotonin type 3 receptor and has antiemetic activity in animals given cisplatin. Its mean serum half-life in 11.1 hours. METHODS In this dose-ranging trial, 22 patients undergoing anti-cancer chemotherapy received 24 courses of a single

Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND RG 12915 is a potent, selective 5-HT3 receptor antagonist with a biologic half-life of 11-20 hours. RG 12915 prevents cisplatin-induced emesis in ferrets at doses of 0.03 mg/kg. Animal toxicology studies permitted safe testing in humans at doses of up to 2.0 mg/kg. This dose-ranging trial

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye